Thiopurine-S-methyltransferase genotype and the response to azathioprine in inflammatory bowel disease

被引:5
|
作者
Stocco, G. [1 ]
Martelossi, S.
Decorti, G.
Bartoli, F.
Ventura, A.
机构
[1] Univ Trieste, Dept Biomed Sci, Trieste, Italy
[2] Univ Trieste, IRCCS Burlo Garofolo, Dept Reprod & Dev Sci, Trieste, Italy
关键词
D O I
10.1111/j.1365-2036.2007.03417.x
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:1083 / 1084
页数:2
相关论文
共 50 条
  • [1] The impact of thiopurine-S-methyltransferase genotype on the adverse drug reactions to azathioprine in patients with inflammatory bowel diseases
    Hlavaty, T.
    Batovsky, M.
    Balakova, D.
    Pav, I
    Celec, P.
    Gregus, M.
    Zakuciova, M.
    Hlista, M.
    Horakova, M.
    Desatova, B.
    Koller, T.
    Toth, J.
    Kadasi, L.
    Huorka, M.
    [J]. BRATISLAVA MEDICAL JOURNAL-BRATISLAVSKE LEKARSKE LISTY, 2013, 114 (04): : 199 - 205
  • [2] Thiopurine Methyltransferase Activity Influences Clinical Response to Azathioprine in Inflammatory Bowel Disease
    Cuffari, Carmen
    Dassopoulos, Themistocles
    Turnbough, Lisa
    Thompson, Richard E.
    Bayless, Theodore M.
    [J]. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2004, 2 (05) : 410 - 417
  • [3] Thiopurine methyltransferase genotype and thiopurine S-methyltransferase activity in Greek children with inflammatory bowel disease
    Gazouli, Maria
    Pachoula, Ioanna
    Panayotou, Ioanna
    Chouliaras, Georgios
    Anagnou, Nicholas P.
    Chroussos, George
    Roma, Eleftheria
    [J]. ANNALS OF GASTROENTEROLOGY, 2012, 25 (03): : 249 - 253
  • [4] Impracticalities of thiopurine-S-methyltransferase determination in daily inflammatory bowel disease practice: authors' reply
    Winter, J
    Mills, PR
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2006, 23 (08) : 1279 - 1280
  • [5] Thiopurine methyltransferase activity and the use of azathioprine in inflammatory bowel disease
    Ansari, A
    Hassan, C
    Duley, J
    Marinaki, A
    Shobowale-Bakre, EM
    Seed, P
    Meenan, J
    Yim, A
    Sanderson, J
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2002, 16 (10) : 1743 - 1750
  • [6] Adverse reactions to azathioprine cannot be predicted by thiopurine S-methyltransferase genotype in Japanese patients with inflammatory bowel disease
    Takatsu, Noritaka
    Matsui, Toshiyuki
    Murakami, Yuji
    Ishihara, Hiroshi
    Hisabe, Takashi
    Nagahama, Takashi
    Maki, Shinichirou
    Beppu, Takahiro
    Takaki, Yasuhiro
    Hirai, Fumihito
    Yao, Kenshi
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2009, 24 (07) : 1258 - 1264
  • [7] Dosing azathioprine in thiopurine S-methyltransferase deficient inflammatory bowel disease patients
    Derijks, L. J. J.
    van Helden, R. B.
    Hommes, D. W.
    Stokkers, P. C.
    [J]. GUT, 2008, 57 (06) : 872 - 872
  • [8] Measurement of thiopurine methyltransferase activity and azathioprine metabolites in patients with inflammatory bowel disease
    Lowry, PW
    Franklin, CL
    Weaver, AL
    Pike, MG
    Mays, DC
    Tremaine, WJ
    Lipsky, JJ
    Sandborn, WJ
    [J]. GUT, 2001, 49 (05) : 665 - 670
  • [9] Efficacy, tolerance of azathioprine and pharmacogenetics of thiopurine methyltransferase in pediatric inflammatory bowel disease
    Zhang, D.
    Languepin, J.
    Medard, Y.
    Cezard, J. P.
    Jacqz-Aigrain, E.
    [J]. FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2001, 15 : 38 - 38
  • [10] Pharmacogenetics of Azathioprine: Efficacy and Toxicity in Thiopurine-S-Methyltransferase Heterozygotes Following Cardiac Transplant
    Liang, Jackson J.
    Geske, Jennifer R.
    Boilson, Barry A.
    Kremers, Walter K.
    Pereira, Naveen L.
    [J]. JOURNAL OF CARDIAC FAILURE, 2012, 18 (08) : S62 - S63